Literature DB >> 18343149

Lung metastasis resection of adenoid cystic carcinoma of salivary glands.

Antonio Bobbio1, Chiara Copelli, Luca Ampollini, Bernardo Bianchi, Paolo Carbognani, Stefano Bettati, Enrico Sesenna, Michele Rusca.   

Abstract

BACKGROUND: Adenoid cystic carcinoma is a rare tumour originating from the exocrine mucous glands, known for its high propensity for distant metastases. The value of lung metastasis resection from adenoid cystic carcinoma of salivary glands origin is evaluated.
METHODS: A retrospective study was conducted on patients undergoing surgery for primary adenoid cystic carcinoma of the salivary glands between 1982 and 2006. Patients were excluded who had primary tumour macroscopic incomplete resection or were lost at follow-up. From a database of 50 eligible patients, 27 were identified as having presented a tumour recurrence during follow-up; in 20 it was first diagnosed in the form of distant metastases, and in 7 in the form of loco-regional recurrence. Nine patients who presented isolated lung recurrence underwent complete lung metastasectomy. Demographic data, pathologic characteristics and operative and postoperative record were reviewed, as well as updated survival.
RESULTS: Twenty-six men and 24 women with a median age of 57 years (range 33-79) underwent radical surgery for adenoid cystic carcinoma during the study period. In 20 patients, at a median free interval time of 3 years (range 1-12), a distant metastasis relapse was observed. Nine patients with a median free interval time of 5 years (range 1-12) underwent lung metastasectomy: five had single metastasis resection, one multiple mono-pulmonary and three multiple and bilateral. In six of these patients a new disease recurrence was noted: four patients underwent further lung metastasectomy, but in all of them progression of the disease was observed. Mean survival of the population as a whole resulted as being 16 years (SE=1.4) with an actuarial survival of 77% at 5 years, 66% at 10 years and 56% at 15 years. Mean survival of patients having presented with distant metastases resulted as being 11 years (SE=2.2). Mean survival after appearance of distant metastases resulted as being 72 months (SE=15.8) in the 9 patients treated by metastasectomy, and 62 months (SE=15.1) in the 11 who did not have metastasis resection.
CONCLUSIONS: Patients with adenoid cystic carcinoma could be frequently encountered with disease recurrence confined to the lung. The impact of complete lung metastasis resection on the course of the disease, however, is yet to be determined.

Entities:  

Mesh:

Year:  2008        PMID: 18343149     DOI: 10.1016/j.ejcts.2007.12.057

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

1.  Recurrent adenoid cystic carcinoma in the liver: a repeated laparoscopic surgical approach.

Authors:  Vincenzo Scuderi; Antonio Ceriello; Marina Romano; Carla Migliaccio; Giuseppina Marino Marsilia; Fulvio Calise
Journal:  Updates Surg       Date:  2011-06-07

2.  Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.

Authors:  Kenta Kawahara; Akimitsu Hiraki; Ryoji Yoshida; Hidetaka Arita; Yuichiro Matsuoka; Toshio Yamashita; Kan-Ichi Koga; Masashi Nagata; Akiyuki Hirosue; Daiki Fukuma; Hideki Nakayama
Journal:  Mol Clin Oncol       Date:  2017-04-21

3.  A report of laryngeal adenocystic carcinoma metastatic to the spleen and the role of splenectomy in the management of metastatic disease: a case report.

Authors:  Bryce W Murray; Lewis C Lyons; Anne T Mancino; Sergio Huerta
Journal:  J Med Case Rep       Date:  2010-07-06

Review 4.  Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments.

Authors:  Luana Guimaraes de Sousa; Katarina Jovanovic; Renata Ferrarotto
Journal:  Curr Treat Options Oncol       Date:  2022-07-19

5.  Metastasectomy for hepatic metastases from adenoid cystic carcinoma of the trachea.

Authors:  Inkeun Park; Sung-Nam Lim; Dok Hyun Yoon; Hyunjoo Park; Byungjoo Sun; Pil Hyung Lee; Ilseon Hwang; Dae Ho Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

6.  Metachronous adenoid cystic carcinoma in the peripheral lung and at base of the tongue.

Authors:  Jun Hyun Kim; Su Hyun Ahn; Jeong Min Kim; So-Yoon Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-08-01       Impact factor: 3.372

7.  Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.

Authors:  Valéria Souza Freitas; Jean Nunes Dos Santos; Pedro Paulo de Andrade Santos; Cassiano Francisco Weege Nonaka; Leão Pereira Pinto; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-25       Impact factor: 2.503

8.  Adenoid Cystic Carcinoma of Buccal Mucosa: Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Detection and Biopsy of Pulmonary Metastases and Assessment of Treatment Response.

Authors:  Ashwin Singh Parihar; Shelvin Kumar Vadi; Bhagwant Rai Mittal; Rajender Kumar; Apurva Sood; Harmandeep Singh; Amit Bahl
Journal:  Indian J Nucl Med       Date:  2019 Jan-Mar

9.  Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma.

Authors:  Melody J Xu; Tara J Wu; Annemieke van Zante; Ivan H El-Sayed; Alain P Algazi; William R Ryan; Patrick K Ha; Sue S Yom
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-04-25

10.  Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma.

Authors:  Joseph Mandelbaum; Ilya A Shestopalov; Rachel E Henderson; Nicole G Chau; Birgit Knoechel; Michael J Wick; Leonard I Zon
Journal:  J Exp Med       Date:  2018-09-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.